Table 2 Criteria, Criterion Weights, Questions, and Answer Choices Selected by Workshop Participants
Criteria | Criterion Weight | Question | Answer Choices |
|---|---|---|---|
Disease occurrence on a regional and local level, and pandemic or epidemic potential | 0.32 | Does the disease occur in Mozambique or neighboring countries in humans or animals, and is there evidence of sustained human-to-human transmission (pandemic potential)? | a. Occurs locally or in neighboring countries, and there is evidence of sustained human-to-human transmission—3 b. Occurs locally or in neighboring countries, and there is no evidence of sustained human-to-human transmission—2 c. Does not occur locally or in neighboring countries, but there is evidence of sustained human-to human transmission—1 d. Does not occur locally or in neighboring countries, and there is no evidence of sustained human to-human transmission—0 |
Morbidity and mortality | 0.28 | What are the morbidity and mortality rates of the disease in humans? | a. CFR (Case fatality rate) ≥ 10%—4 b. Long-term disability (Yes) and CFR < 10%—3 c. Long-term disability (No) and CFR < 10%—2 d. Long-term disability (Yes) and CFR is zero—1 e. Long-term disability (No) and CFR is zero—0 |
Capacity of laboratory diagnostics and epidemiological surveillance | 0.14 | Does laboratory capacity and/or epidemiological surveillance exist for the human health and/or animal health sector in Mozambique? | a. Both laboratory and surveillance capacity exists for humans and animals—2 b. Some form of laboratory or surveillance capacity exists for humans or animals—1 c. No laboratory or surveillance capacity exists for neither humans or animals—0 |
Availability of resources and mechanisms for collaboration, prevention, treatment, and eradication of disease | 0.13 | Is there a response plan for the disease in Mozambique and is there a vaccine or treatment available in the country? | a. A response plan exists in at least one sector in country and a vaccine and/or treatment is available in country for at least one sector—2 b. A response plan exists in at least one sector in country or a vaccine or treatment is available in country for at least sector -1 c. No response plan exists in country and no vaccine or treatment is available in country—0 |
Social, economic, and environmental impact of the disease | 0.10 | Is the disease on the OIE reportable disease list? | a. Yes – 1 b. No—0 |